Prakt. Lékáren. 2019; 15(4e): 3-8
For the treatment and prevention of ocular diseases, most patients are treated with conventional drug delivery formulations such as eye drops or
ointments. Their disadvantage is the low bioavailability of the drug and frequent application. The new trends in the development of ophthalmic
preparations include the use of modern excipients and dosage forms to achieve higher bioavailability of the drug. However, only a few modern devices
have come into common clinical practice while others are being investigated in clinical trials.
Published: December 1, 2019 Show citation